InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,490.24
(
0.06%
)
US TECH 100
19,413.80
(
0.03%
)
Dow Jones
38,923.75
(
0.23%
)
Brent Oil
84.76
(
0.07%
)
Bitcoin
64,903.94
(
-0.10%
)
Post# of 27525
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Katfish

Send PM Follow Ignore
Followers 79
Posts 24611
Boards Moderated 1
Alias Born 09/08/2000

Katfish

Member Level

Re: None

Tuesday, 03/26/2024 8:55:55 AM

Tuesday, March 26, 2024 8:55:55 AM

Post# of 27525
MESO - 2.20 Pre-market at 2.85/2.87

Mesoblast shares are trading higher after the FDA informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L for treatment of pediatric patients with steroid-refractory acute graft versus host disease.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up